Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease

Recruiting N/A Interventional Study
Insomnia Chronic Coronary Heart Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
76 (estimated)
Sponsor
Vestre Viken Hospital Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Insomnia is prevalent (45%) in CHD patients and associated with significantly increased risk for recurrent cardiovascular events. Insomnia has recently been identified as the third most important risk factor for prognosis. However, very few insomnia patients are identified and receive treatment of insomnia today. CBT-I is the first-line treatment for insomnia, but studies on the effects in CHD pat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria (all the following): * Aged 18-75 years and signed informed consent and expected cooperation according to ICH/GCP and national/local regulations * Hospitalised with acute myocardial infarction and/or angiography-verified coronary atherosclerosis, or a coronary revascularisation p…
Contacts

John D Munkhaugen, MD, PhD

+4797524194

johmun@vestreviken.no

CONTACT

Toril Dammen, MD, PhD

+4790163433

toril.dammen@medisin.uio.no

CONTACT